Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer
Clinical trial NCT07049133 · RECRUITING
Trial details
- NCT number
- NCT07049133
- Sponsor
- European Institute of Oncology
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-31
- Primary completion
- 2027-12-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.